Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Novel recruitment strategy to enrich for LRRK 2mutation carriers

6 May 2015

Abstract excerpt

The LRRK2 G2019S mutation is found at higher frequency among Parkinson disease (PD) patients of Ashkenazi Jewish (AJ) ancestry. This study was designed to test whether an internet-based approach could be an effective approach to screen and identify mutation carriers. Individuals with and without PD of AJ ancestry were recruited and consented through an internet-based study website. An algorithm was applied to a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Fungal and yeast genetics research
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26436106
DOI: 10.1002/mgg3.151

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Novel recruitment strategy to enrich for LRRK 2mutation carriersPMID 26436106Read ↗

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.Semantic proximity Read ↗

An Exploratory Study Using Electronic Medical Records to Assess the Feasibility of Establishing Cohorts of Patients with Genetic Causes of Parkinson's Disease.Semantic proximity Read ↗

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.Semantic proximity Read ↗

Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.Semantic proximity Read ↗

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews.Semantic proximity Read ↗

Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations.Semantic proximity Read ↗

Age-specific penetrance ofLRRK2G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumSemantic proximity Read ↗

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.Semantic proximity Read ↗

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.Semantic proximity Read ↗

Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study.Semantic proximity Read ↗

Test for LRRK2 mutations in patients with Parkinson's disease.Semantic proximity Read ↗

Motor progression of Parkinson's disease with the leucine-rich repeat kinase 2 G2019S mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.